Nifty
Sensex
:
:
23501.10
77209.90
-65.90 (-0.28%)
-269.03 (-0.35%)

Pharmaceuticals & Drugs - Domestic

Rating :
39/99

BSE: 531349 | NSE: PANACEABIO

132.66
21-Jun-2024
  • Open
  • High
  • Low
  • Previous Close
  •  134.02
  •  135.50
  •  129.89
  •  134.13
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  140024
  •  186.79
  •  202.50
  •  112.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 811.57
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 693.08
  • N/A
  • 0.96

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.59%
  • 2.61%
  • 19.90%
  • FII
  • DII
  • Others
  • 0.27%
  • 0.00%
  • 3.63%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.03
  • 0.14
  • -9.71

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.79
  • -5.95
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -11.41
  • -
  • -38.98

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 0.58
  • 0.58

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -3.57
  • 4.56
  • 0.63

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.04
  • -3.00
  • -9.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
136.46
128.93
5.84%
150.50
115.20
30.64%
143.02
105.12
36.05%
129.19
110.70
16.70%
Expenses
142.50
134.60
5.87%
150.65
123.84
21.65%
146.58
108.96
34.53%
139.50
190.51
-26.78%
EBITDA
-6.04
-5.67
-
-0.15
-8.64
-
-3.56
-3.84
-
-10.31
-79.81
-
EBIDTM
-4.43%
-4.40%
-0.10%
-7.50%
-2.49%
-3.65%
-7.98%
-72.10%
Other Income
10.81
15.06
-28.22%
5.68
13.94
-59.25%
3.23
10.45
-69.09%
6.08
12.21
-50.20%
Interest
0.82
1.05
-21.90%
0.85
0.96
-11.46%
0.91
1.18
-22.88%
1.00
1.25
-20.00%
Depreciation
8.81
9.51
-7.36%
9.11
9.67
-5.79%
9.31
9.89
-5.86%
9.48
10.05
-5.67%
PBT
-2.12
18.21
-
-1.65
22.44
-
-7.78
23.31
-
13.03
-51.16
-
Tax
-0.13
30.89
-
0.55
3.07
-82.08%
0.51
7.61
-93.30%
2.05
4.98
-58.84%
PAT
-1.99
-12.68
-
-2.20
19.37
-
-8.29
15.70
-
10.98
-56.14
-
PATM
-1.46%
-9.83%
-1.46%
16.81%
-5.80%
14.94%
8.50%
-50.71%
EPS
-0.23
-2.02
-
-0.36
3.16
-
-1.35
2.56
-
1.79
-9.16
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
559.17
459.95
661.23
624.80
544.06
456.70
592.79
544.01
653.08
687.19
509.99
Net Sales Growth
21.57%
-30.44%
5.83%
14.84%
19.13%
-22.96%
8.97%
-16.70%
-4.96%
34.75%
 
Cost Of Goods Sold
230.12
252.66
262.20
204.63
156.79
172.24
187.25
149.52
215.81
280.21
214.00
Gross Profit
329.05
207.29
399.03
420.17
387.27
284.45
405.55
394.50
437.27
406.98
295.99
GP Margin
58.85%
45.07%
60.35%
67.25%
71.18%
62.28%
68.41%
72.52%
66.96%
59.22%
58.04%
Total Expenditure
579.23
557.90
674.43
548.18
518.57
589.83
508.26
496.89
541.37
643.31
592.00
Power & Fuel Cost
-
31.95
37.82
30.94
29.74
34.55
33.52
30.55
25.15
30.73
31.74
% Of Sales
-
6.95%
5.72%
4.95%
5.47%
7.57%
5.65%
5.62%
3.85%
4.47%
6.22%
Employee Cost
-
126.48
182.97
156.17
144.42
147.08
151.59
148.12
142.02
135.98
144.92
% Of Sales
-
27.50%
27.67%
25.00%
26.54%
32.20%
25.57%
27.23%
21.75%
19.79%
28.42%
Manufacturing Exp.
-
47.24
78.70
43.22
33.38
44.31
40.05
41.88
39.47
43.97
52.69
% Of Sales
-
10.27%
11.90%
6.92%
6.14%
9.70%
6.76%
7.70%
6.04%
6.40%
10.33%
General & Admin Exp.
-
43.77
53.79
47.48
54.20
71.07
40.39
52.98
39.41
56.82
60.39
% Of Sales
-
9.52%
8.13%
7.60%
9.96%
15.56%
6.81%
9.74%
6.03%
8.27%
11.84%
Selling & Distn. Exp.
-
42.70
48.08
51.18
42.81
31.27
36.98
37.70
44.20
44.20
46.09
% Of Sales
-
9.28%
7.27%
8.19%
7.87%
6.85%
6.24%
6.93%
6.77%
6.43%
9.04%
Miscellaneous Exp.
-
13.10
10.86
14.56
57.24
89.31
18.48
36.14
35.31
51.40
46.09
% Of Sales
-
2.85%
1.64%
2.33%
10.52%
19.56%
3.12%
6.64%
5.41%
7.48%
8.27%
EBITDA
-20.06
-97.95
-13.20
76.62
25.49
-133.13
84.53
47.12
111.71
43.88
-82.01
EBITDA Margin
-3.59%
-21.30%
-2.00%
12.26%
4.69%
-29.15%
14.26%
8.66%
17.11%
6.39%
-16.08%
Other Income
25.80
51.66
10.97
9.98
30.35
5.06
8.23
46.59
20.35
28.48
15.36
Interest
3.58
4.44
180.84
185.34
173.98
104.83
100.58
100.93
127.33
104.53
150.30
Depreciation
36.71
39.12
43.78
45.59
44.13
55.03
58.53
67.95
73.32
67.24
71.10
PBT
1.48
-89.86
-226.85
-144.32
-162.28
-287.93
-66.35
-75.17
-68.59
-99.41
-288.05
Tax
2.98
46.55
371.02
1.96
16.95
8.56
9.86
-10.98
1.92
3.08
1.68
Tax Rate
201.35%
363.67%
25.60%
-1.36%
-9.54%
18.58%
-14.86%
16.28%
-10.14%
-3.10%
-1.51%
PAT
-1.50
-33.23
1,078.31
-146.24
-194.60
37.58
-74.18
-54.75
-18.51
-100.70
-111.56
PAT before Minority Interest
-0.94
-33.74
1,078.33
-146.20
-194.63
37.52
-76.20
-56.47
-20.85
-102.49
-112.64
Minority Interest
0.56
0.51
-0.02
-0.04
0.03
0.06
2.02
1.72
2.34
1.79
1.08
PAT Margin
-0.27%
-7.22%
163.08%
-23.41%
-35.77%
8.23%
-12.51%
-10.06%
-2.83%
-14.65%
-21.87%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-0.24
-5.42
175.91
-23.86
-31.75
6.13
-12.10
-8.93
-3.02
-16.43
-18.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
843.60
876.64
-228.69
198.79
350.40
308.68
355.68
448.61
471.29
512.72
Share Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
22.43
22.43
6.13
Total Reserves
837.48
870.51
-234.82
160.66
344.27
302.55
349.55
426.18
448.76
506.59
Non-Current Liabilities
99.22
85.10
959.99
740.66
70.08
591.13
718.78
1,100.11
918.47
767.07
Secured Loans
0.18
0.24
675.05
583.55
8.90
560.45
704.57
866.08
721.77
581.77
Unsecured Loans
19.98
33.87
60.03
29.58
37.22
10.26
9.49
1.00
1.20
1.40
Long Term Provisions
26.55
29.16
30.65
42.74
39.78
26.54
18.36
184.42
180.43
180.47
Current Liabilities
329.73
773.77
449.09
622.14
938.26
695.52
689.13
474.80
706.03
826.82
Trade Payables
177.32
234.72
246.66
198.85
269.71
277.19
248.60
187.87
209.13
252.11
Other Current Liabilities
115.71
503.01
189.06
242.12
585.25
242.00
237.52
93.60
194.85
251.91
Short Term Borrowings
0.00
0.00
0.00
3.57
69.39
164.88
190.71
191.82
295.84
320.67
Short Term Provisions
36.70
36.03
13.37
177.60
13.92
11.44
12.30
1.51
6.21
2.13
Total Liabilities
1,269.06
1,732.53
1,177.39
1,558.55
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
Net Block
599.95
622.07
608.70
657.39
805.56
948.97
1,001.37
1,071.11
1,144.30
1,275.54
Gross Block
1,330.83
1,313.94
1,266.39
1,282.22
1,392.90
1,605.84
1,600.07
1,620.29
1,633.48
1,697.63
Accumulated Depreciation
730.88
691.87
657.69
624.84
587.34
656.87
598.70
549.18
489.18
422.09
Non Current Assets
702.85
744.57
666.41
875.27
847.84
1,027.55
1,070.91
1,475.22
1,573.49
1,739.28
Capital Work in Progress
42.32
17.26
34.42
24.01
22.51
39.92
30.41
115.78
110.31
116.55
Non Current Investment
0.07
0.07
0.07
5.58
5.33
5.25
7.01
5.19
10.20
15.97
Long Term Loans & Adv.
56.76
21.46
17.62
187.70
13.33
28.01
22.03
236.71
262.44
274.94
Other Non Current Assets
3.74
83.71
5.61
0.60
1.12
5.39
10.09
1.26
1.07
0.35
Current Assets
562.32
950.55
510.97
683.27
507.89
564.83
703.22
549.38
525.72
372.81
Current Investments
13.42
5.00
0.00
0.00
0.00
2.03
0.27
3.52
4.98
0.00
Inventories
202.09
212.72
174.14
147.69
81.43
334.21
315.55
305.24
310.22
219.81
Sundry Debtors
60.09
81.66
84.68
68.52
88.73
136.01
142.17
141.67
98.57
94.93
Cash & Bank
225.99
583.28
135.79
89.75
23.48
23.24
14.13
22.93
52.40
24.78
Other Current Assets
60.72
8.75
52.64
335.69
314.25
69.36
231.09
76.02
59.55
33.29
Short Term Loans & Adv.
52.31
59.15
63.72
41.62
41.02
59.30
56.21
66.76
50.15
24.72
Net Current Assets
232.59
176.79
61.88
61.13
-430.38
-130.69
14.08
74.58
-180.31
-454.01
Total Assets
1,265.17
1,695.12
1,177.38
1,558.54
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
-422.45
-108.45
106.76
-30.47
104.80
118.02
130.67
90.69
37.23
53.73
PBT
12.81
1,449.36
-145.03
-177.34
46.23
-66.14
-67.18
-18.93
-99.41
-110.96
Adjustment
-95.87
-1,454.97
230.88
253.04
-70.58
166.62
149.57
148.75
167.45
59.92
Changes in Working Capital
-336.91
300.86
21.91
-97.50
127.32
21.45
43.32
-58.26
-25.16
107.22
Cash after chg. in Working capital
-419.98
295.25
107.76
-21.80
102.97
121.93
125.71
71.56
42.88
56.18
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.48
-403.70
-1.00
-8.67
1.83
-3.91
4.96
19.13
-5.65
-2.45
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
430.33
1,282.57
-47.68
-34.76
-5.27
55.29
-25.83
16.44
-37.38
-37.60
Net Fixed Assets
-13.92
-26.71
28.01
223.59
488.74
-15.06
-27.48
11.93
-29.48
-5.26
Net Investments
0.00
0.00
54.26
-51.99
342.34
0.00
49.78
0.00
-0.46
-122.35
Others
444.25
1,309.28
-129.95
-206.36
-836.35
70.35
-48.13
4.51
-7.44
90.01
Cash from Financing Activity
-18.37
-1,175.84
-47.11
90.74
-101.14
-164.35
-106.96
-117.38
-0.70
-30.26
Net Cash Inflow / Outflow
-10.49
-1.72
11.97
25.51
-1.61
8.97
-2.13
-10.25
-0.85
-14.13
Opening Cash & Equivalents
50.35
52.08
40.22
14.47
16.44
7.47
9.59
19.97
20.84
34.95
Closing Cash & Equivalent
39.85
50.35
52.08
40.22
14.47
16.44
7.47
9.73
19.99
20.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
137.73
143.12
-37.34
27.23
57.21
50.40
58.07
-4.43
-0.75
13.96
ROA
-2.24%
74.05%
-10.69%
-13.36%
2.55%
-4.53%
-2.97%
-1.01%
-4.87%
-5.47%
ROE
-3.92%
332.85%
0.00%
-75.26%
11.39%
-22.94%
-34.38%
0.00%
-253.03%
-76.49%
ROCE
1.94%
217.12%
5.36%
-0.38%
13.44%
2.63%
2.76%
9.93%
0.45%
3.37%
Fixed Asset Turnover
0.36
0.54
0.51
0.41
0.30
0.37
0.35
0.40
0.41
0.30
Receivable days
54.62
43.66
42.68
52.75
89.81
85.16
92.84
67.10
51.36
58.89
Inventory Days
159.84
101.55
89.66
76.86
166.09
198.91
203.06
171.89
140.68
174.32
Payable days
297.63
335.05
397.33
178.20
213.56
186.55
163.89
130.73
137.37
148.94
Cash Conversion Cycle
-83.17
-189.84
-264.98
-48.60
42.34
97.52
132.00
108.26
54.67
84.27
Total Debt/Equity
0.02
0.04
-3.58
4.45
1.85
3.05
2.79
-100.22
93.42
12.38
Interest Cover
3.89
9.01
0.22
-0.02
1.44
0.34
0.33
0.85
0.05
0.26

News Update:


  • Panacea Biotec - Quarterly Results
    30th May 2024, 14:22 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.